Metabolomics Classification via LightGBM and SHAP Feature Selection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current metabolomics methods for diagnosing and prognosing diseases are hindered by the lack of commercial software for quantitative analysis, leading to manual inputs, subjective interpretations, low reproducibility, and time-consuming processes, especially in untargeted approaches that handle large datasets with over 20,000 compounds.
Innovation Solution
A computer-implemented method using LightGBM and random forest machine learning models, combined with SHAP for feature selection, to generate diagnostic or prognostic indications from metabolite feature data obtained through mass spectrometry, enabling the identification of selective metabolite features for disorders like influenza or autoimmune diseases.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If manual methods are used for metabolomics data analysis, then flexibility in handling diverse datasets is maintained, but analysis time increases and reproducibility decreases
Solution Approach 1:
The patent replaces manual mechanical analysis processes with automated machine learning systems. LightGBM and random forest algorithms automatically process metabolomics data, eliminating the need for manual data manipulation while maintaining adaptability to diverse datasets through parameter tuning and feature selection mechanisms.
Solution Approach 2:
The system changes parameters dynamically to adapt to different datasets. The machine learning models adjust hyperparameters, feature importance weights, and selection criteria based on the specific characteristics of each metabolomics dataset, providing both automation and adaptability.
2Measurement precision
If comprehensive metabolite measurements are performed on large datasets, then diagnostic accuracy improves, but data complexity and processing difficulty increase
Solution Approach 1:
The patent extracts only the most relevant metabolite features from comprehensive datasets using SHAP (SHapley Additive exPlanations) methodology. This feature selection process identifies and extracts key diagnostic metabolites while discarding redundant information, reducing data complexity while preserving diagnostic accuracy.
Solution Approach 2:
The complex metabolomics data is segmented into meaningful groups based on feature importance and biological relevance. The system divides the large dataset into core diagnostic features and secondary features, making the data more manageable and interpretable while maintaining comprehensive analysis capabilities.
3Reliability
If automated machine learning models are used for metabolomics analysis, then reproducibility and efficiency improve, but interpretability of results decreases
Solution Approach 1:
The patent implements feedback mechanisms through SHAP values that explain how each metabolite feature contributes to the diagnostic prediction. This provides interpretable feedback on the machine learning model's decision-making process, allowing clinicians to understand which metabolites drive the diagnosis while maintaining automated reproducibility.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides accurate, reproducible, and comprehensive diagnostic or prognostic indications, reducing manual input and increasing efficiency, allowing for point-of-care diagnostics and treatment decisions without genetic or molecular data, with high sensitivity and specificity in distinguishing between disease states.
Implementation Method 1
The metabolites present in biological systems include endogenously derived biochemicals. In general, metabolomics is a valuable tool in different disciplines such as drug discovery, biomarker research, studies of diseases, and metabolic pathways confirmation.
Implementation Method 2
the processed sample is obtained from eluting and processing a raw subject sample by liquid chromatography
Implementation Method 3
the in-line chromatography comprises reverse phase chromatography followed by ion exchange chromatography
Implementation Method 4
the in-line chromatography comprises reverse phase chromatography followed by ion exchange chromatography
Implementation Method 5
the eluting and processing comprises ultrafiltration of the raw subject sample
Data Source
AI summary
The present invention relates to systems, methods and devices for metabolomic-based classification of biological samples, and interpretation methods for biomarker discovery.